Literature DB >> 29174383

Intracerebroventricular streptozotocin impairs adult neurogenesis and cognitive functions via regulating neuroinflammation and insulin signaling in adult rats.

Sandeep Kumar Mishra1, Sonu Singh2, Shubha Shukla1, Rakesh Shukla3.   

Abstract

Neurogenesis is a complex process involved in memory formation and is known to be altered in Alzheimer's disease (AD). Neuroinflammation and insulin signaling dysfunction, key players during intracerebroventricular Streptozotocin (ICV-STZ) induced dementia variedly affects neurogenesis. The aim of this work was to study the variation in neurogenic process associated with AD in ICV STZ induced dementia. Adult male Sprague Dawley rats weighing 180-200 g were given two different doses of ICV STZ (3 mg/kg on Day 1 and 3, & 1 mg/kg on Day 1) in two different experimental setup. Memory functions were assessed by Morris Water Maze. Immunofluorescence and western blotting was done to study the variation in neurogenesis, amyloid and tau pathology, neuroinflammation and insulin signaling. ICV STZ 6 mg/kg (3 mg/kg twice on Day 1 and 3 of 21 days study) caused impairment in learning and memory and severe atrophy of the neurogenic areas. Modified dose of ICV STZ (1 mg/kg once on Day 1) caused a significant decline in neurogenesis in subventricular zone (SVZ) and dentate gyrus (DG) as indicated by decrease in the number of (5-Bromo-2'-deoxyuridine) BrdU+ Nestin+ cells, Doublecortin (DCX+) cells and BrdU+ NeuN+ cells after day 11 and 18 of ICV STZ injection. However, impairment in learning and memory was observed only during 18 days study post ICV STZ injection (1 mg/kg on Day 1). Up regulation of proteins of amyloid and tau pathology (Amyloid precursor protein (APP), β site amyloid precursor protein cleaving enzyme 1 (BACE1) & p-Tau Ser 396) was observed at this time point with no significant change in amyloid β42 (Aβ42) expression. Enhanced neuroinflammation (increased Glial fibrillary acidic protein (GFAP) & nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB)) and diminished insulin signaling was also observed in our study in both neurogenic areas, however the extent to which they may have negative impact on neurogenes is yet to be explored.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Dementia; ICV streptozotocin; Insulin signaling; Neurogenesis; Neuroinflammation

Mesh:

Substances:

Year:  2017        PMID: 29174383     DOI: 10.1016/j.neuint.2017.11.012

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  11 in total

1.  Investigation Covering the Effect of Boron plus Taurine Application on Protein Carbonyl and Advanced Oxidation Protein Products Levels in Experimental Alzheimer Model.

Authors:  Cigdem Yildirim; Atiye Seda Yar Saglam; Sevin Guney; Burak Turan; Meral Ebegil; Sule Coskun Cevher; Barbaros Balabanli
Journal:  Biol Trace Elem Res       Date:  2022-05-27       Impact factor: 3.738

2.  Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer's Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway.

Authors:  Noorul Hasan; Saima Zameer; Abul Kalam Najmi; Suhel Parvez; Mohd Akhtar
Journal:  Neurotox Res       Date:  2022-02-22       Impact factor: 3.911

3.  Quercetin Exhibits α7nAChR/Nrf2/HO-1-Mediated Neuroprotection Against STZ-Induced Mitochondrial Toxicity and Cognitive Impairments in Experimental Rodents.

Authors:  Niraj Kumar Singh; Debapriya Garabadu
Journal:  Neurotox Res       Date:  2021-09-23       Impact factor: 3.911

4.  Toxic Effect of Streptozotocin on Cultured Mouse Hippocampal Neurons.

Authors:  E E Genrikhs; M R Kapkaeva; E V Stelmashook; N K Isaev; L G Khaspekov
Journal:  Bull Exp Biol Med       Date:  2021-10-27       Impact factor: 0.804

5.  Prenatal Venlafaxine Exposure-Induced Neurocytoarchitectural and Neuroapoptotic Degeneration in Striatum and Hippocampus of Developing Fetal Brain, Manifesting Long-term Neurocognitive Impairments in Rat Offspring.

Authors:  K P Singh; Prashant Sharma; Manish Singh
Journal:  Neurotox Res       Date:  2022-07-12       Impact factor: 3.978

6.  Intranasal Insulin Enhances Intracerebroventricular Streptozotocin-Induced Decrease in Olfactory Discriminative Learning via Upregulation of Subventricular Zone-Olfactory Bulb Neurogenesis in the Rat Model.

Authors:  Sandeep K Mishra; Mahendra Hidau
Journal:  Mol Neurobiol       Date:  2020-10-29       Impact factor: 5.590

7.  Memantine and Ibuprofen pretreatment exerts anti-inflammatory effect against streptozotocin-induced astroglial inflammation via modulation of NMDA receptor-associated downstream calcium ion signaling.

Authors:  Sandeep K Mishra; Mahendra Hidau; Shivika Rai
Journal:  Inflammopharmacology       Date:  2020-10-07       Impact factor: 4.473

8.  Additional methodological considerations regarding optimization of the dose of intracerebroventricular streptozotocin A response to: "Optimization of intracerebroventricular streptozotocin dose for the induction of neuroinflammation and memory impairments in rats" by Ghosh et al., Metab Brain Dis 2020 July 21.

Authors:  Jan Homolak; Ana Babic Perhoc; Ana Knezovic; Jelena Osmanovic Barilar; Melita Salkovic-Petrisic
Journal:  Metab Brain Dis       Date:  2020-10-27       Impact factor: 3.584

9.  Impaired Learning and Memory Ability Induced by a Bilaterally Hippocampal Injection of Streptozotocin in Mice: Involved With the Adaptive Changes of Synaptic Plasticity.

Authors:  Cong-Cong Qi; Xing-Xing Chen; Xin-Ran Gao; Jing-Xian Xu; Sen Liu; Jin-Fang Ge
Journal:  Front Aging Neurosci       Date:  2021-03-01       Impact factor: 5.750

10.  Dimethyl Fumarate as the Peripheral Blood Inflammatory Mediators Inhibitor in Prevention of Streptozotocin-Induced Neuroinflammation in Aged Rats.

Authors:  Danuta Wrona; Irena Majkutewicz; Grzegorz Świątek; Joanna Dunacka; Beata Grembecka; Wojciech Glac
Journal:  J Inflamm Res       Date:  2022-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.